ALNY: Alnylam Pharmaceuticals, Inc. Stock

by  •  • Comments Off on ALNY: Alnylam Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 32,741.83
Enterprise Value ($M) 34,168.36
Book Value ($M) 115.44
Book Value / Share 0.89
Price / Book 283.64
NCAV ($M) -830.12
NCAV / Share -6.37
Price / NCAV -39.44

Profitability (mra)
Return on Invested Capital (ROIC) -0.10
Return on Assets (ROA) -0.07
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 2.98
Current Ratio 3.04

Balance Sheet (mrq) ($M)
Current Assets 3,268.26
Assets 4,213.81
Liabilities 4,098.38
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2,248.24
Operating Income -176.88
Net Income -278.16
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -8.31
Cash from Investing -116.84
Cash from Financing 294.16

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-07 13G/A Vanguard Group Inc 10.03 9.32
02-13 13G Capital Research Global Investors 5.40
11-12 13G/A Fmr Llc 11.48 11.23
11-08 13G/A Wellington Management Group Llp 3.91 -30.80
07-05 13G/A Baillie Gifford & Co 4.77 -13.41

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 170,955 604,891 28.26
2025-05-08 382,581 1,560,320 24.52
2025-05-07 131,446 550,309 23.89
2025-05-06 517,911 1,330,090 38.94

(click for more detail)

Similar Companies
ALKS – Alkermes plc ALLK – Allakos Inc.
ALLO – Allogene Therapeutics, Inc. ALXO – ALX Oncology Holdings Inc.
AMGN – Amgen Inc.


Financial data and stock pages provided by
Fintel.io